PharmaInsights

Last week, the eyes of all the key stakeholders in the Antibody Drug Conjugates (ADCs) space were on the developments happening in San…

Last week, I came across an interesting article by Andrew Dunn titled Sanofi investing in gene therapy as R&D focus turns toward rare…

Last week, I wrote an article on the key innovators in ADC therapeutics space, highlighting the key winners at the 6th World ADC Awards…

From being a thing of science fiction to topping the priority list of every big pharma player, gene therapies have come a long way. With…

Cancer is known to be one of the leading causes of death worldwide, accounting for more than 600,000 deaths in 2018 in the US alone. As…

T-Cell immunotherapies have gained a lot of traction in recent years. With a plethora of clinical evidence and billions of dollars in…